Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy
Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a two-arm randomized clinical trial in which 80 participants with Vitamin D
deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1)
prescribed vitamin D replacement or 2) standard of care.
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins